
    
      Approximately 398 subjects (796 eyes) will be enrolled in this three-month controlled,
      parallel group, masked, randomized study at approximately 22 investigative sites in the
      United States (US). Approximately one-half of the subjects will be randomized to receive
      Bausch & Lomb investigational NNR06 Multi-Purpose Solution to be used with a rub care regimen
      (Test), and approximately one-half of the subjects will be randomized to receive COMPLETE
      Multi-Purpose Solution with a rub care regimen (Control).
    
  